表紙
市場調查報告書

陣發性夜間血尿症 (PNH)的全球市場:產業分析、市場規模、市場佔有率、成長率、市場趨勢、預測

Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

出版商 Value Market Research 商品編碼 838359
出版日期 內容資訊 英文 90 Pages
商品交期: 最快1-2個工作天內
價格
陣發性夜間血尿症 (PNH)的全球市場:產業分析、市場規模、市場佔有率、成長率、市場趨勢、預測 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026
出版日期: 2020年05月01日內容資訊: 英文 90 Pages
簡介

本報告提供全球陣發性夜間血尿症 (PNH) 市場調查,市場定義和概要,價值鏈,市場成長的各種影響因素及市場機會分析,各治療方法、地區的趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 摘要整理

第3章 市場分析

  • 簡介
  • 價值鏈分析
  • 成長推動因素
  • 阻礙成長要素
  • 市場機會
  • 波特的五力分析

第4章 陣發性夜間血尿症 (PNH) 治療市場分析:各治療法

  • 藥物療法市場
  • 幹細胞移植市場
  • 輸血市場

第5章 陣發性夜間血尿症 (PNH) 市場分析:各地區

  • 北美
  • 歐洲 (EU)
  • 亞太地區
  • 南美
  • 中東、非洲 (MEA)

第6章 競爭環境

  • 市場競爭
  • 聯盟、合作、協定
  • M&A
  • 新產品的開發
  • 其他

第7章 企業簡介

  • Alexion Pharmaceuticals, Inc.
  • Akari Therapeutics
  • Apellis Pharmaceuticals, Inc.
  • Amgen, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • CinnaGen Co, Plc
  • Ra Pharmaceuticals, Inc.
  • Tentative TOC

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Value Market Research's latest report on the Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2020-2026.

The global paroxysmal nocturnal hemoglobinuria (pnh) treatment market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global paroxysmal nocturnal hemoglobinuria (pnh) treatment market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global paroxysmal nocturnal hemoglobinuria (pnh) treatment market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global paroxysmal nocturnal hemoglobinuria (pnh) treatment market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global paroxysmal nocturnal hemoglobinuria (pnh) treatment market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global paroxysmal nocturnal hemoglobinuria (pnh) treatment market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global paroxysmal nocturnal hemoglobinuria (pnh) treatment market.

The market analysis involves a section exclusively to list the major players of the global paroxysmal nocturnal hemoglobinuria (pnh) treatment market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Report Segments the market as below -

By Treatment

Medication

Stem Cell Transplant

Blood Transfusion

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
  • 2.2. Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Snapshot

3 . PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
  • 3.3. Market Restraints of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
  • 3.4. Opportunities of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
  • 3.5. Trends of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
  • 3.6. Porter's Five Force Analysis of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market
  • 3.7. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Treatment
    • 3.7.2 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Value Chain Analysis
  • 4.2. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Raw Material Manufactures List
    • 4.2.3. Price Trend of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET ANALYSIS BY TREATMENT

  • 5.1 Overview by Treatment
  • 5.2 Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment
  • 5.3 Market Analysis of Medication by Regions
  • 5.4 Market Analysis of Stem Cell Transplant by Regions
  • 5.5 Market Analysis of Blood Transfusion by Regions

6 . GLOBAL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 6.1. Regional Outlook
  • 6.2. Introduction
  • 6.3. North America
    • 6.3.1. Overview
    • 6.3.2. North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
    • 6.3.3. North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
    • 6.3.4. United State
    • 6.3.5. Rest of North America
  • 6.4. Europe
    • 6.4.1. Overview
    • 6.4.2. Europe Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
    • 6.4.3. Europe Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
    • 6.4.4. United Kingdom
    • 6.4.5. France
    • 6.4.6. Germany
    • 6.4.6 Rest of Europe
  • 6.5. Asia Pacific
    • 6.5.1. Overview
    • 6.5.2. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
    • 6.5.3. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
    • 6.5.4. China
    • 6.5.5. Japan
    • 6.5.6. India
    • 6.5.6. Rest of Asia Pacific
  • 6.6. Latin America
    • 6.6.1. Overview
    • 6.6.2. Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
    • 6.6.3. Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
    • 6.6.4. Brazil
    • 6.6.5. Rest of Latin America
  • 6.7. Middle East & Africa
    • 6.7.1. Overview
    • 6.7.2. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Market Segment
    • 6.7.3. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country
    • 6.7.4. Middle East
    • 6.7.5. Africa

7 . COMPETITIVE LANDSCAPE OF THE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT COMPANIES

  • 7.1. Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Competition
  • 7.2. Partnership/Collaboration/Agreement
  • 7.3. Merger And Acquisitions
  • 7.4. New Product Launch
  • 7.5. Other Developments

8 . COMPANY PROFILES OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATMENT INDUSTRY

  • 8.1. Company Share Analysis
  • 8.2. Market Concentration Rate
  • 8.3. Alexion Pharmaceuticals, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Financials
    • 8.3.3. Products
    • 8.3.4. Recent Developments
  • 8.4. Akari Therapeutics
    • 8.4.1. Company Overview
    • 8.4.2. Financials
    • 8.4.3. Products
    • 8.4.4. Recent Developments
  • 8.5. Apellis Pharmaceuticals, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Financials
    • 8.5.3. Products
    • 8.5.4. Recent Developments
  • 8.6. Amgen, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Financials
    • 8.6.3. Products
    • 8.6.4. Recent Developments
  • 8.7. Alnylam Pharmaceuticals, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Financials
    • 8.7.3. Products
    • 8.7.4. Recent Developments
  • 8.8. CinnaGen Co, Plc
    • 8.8.1. Company Overview
    • 8.8.2. Financials
    • 8.8.3. Products
    • 8.8.4. Recent Developments
  • 8.9. Ra Pharmaceuticals, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Financials
    • 8.9.3. Products
    • 8.9.4. Recent Developments

9. IMPACT ANALYSIS OF COVID_19 OUTBREAK

  • 9.1. Impact Analysis of Covid-19 Outbreak on the Market
    • 9.1.1. Direct Impact on Production
    • 9.1.2. Supply Chain and Market Disruption
    • 9.1.3. Financial Impact on Firms and Financial Markets
  • 9.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 9.3. Pre V/S Post COVID-19 Market
  • 9.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
  • 9.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Medication by Geography (USD MN)
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Stem Cell Transplant by Geography (USD MN)
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Blood Transfusion by Geography (USD MN)
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market by Geography (USD MN)
  • North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country (USD MN)
  • United State Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Rest of North America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Europe Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • United Kingdom Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • France Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Germany Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Rest of Europe Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country (USD MN)
  • China Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Japan Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • India Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Rest of Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country (USD MN)
  • Brazil Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Rest of Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Treatment (USD MN)
  • Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Estimate by Country (USD MN)
  • Middle East Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019

LIST OF FIGURES

  • Research Scope of Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Treatment
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis by Treatment (USD MN)
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Medication by Geography (USD MN)
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Stem Cell Transplant by Geography (USD MN)
  • Global Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market Analysis in Blood Transfusion by Geography (USD MN)
  • Latin America Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market by Revenue
  • Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Market by Revenue
  • Recent Development in Paroxysmal Nocturnal Hemoglobinuria (Pnh) Treatment Industry
  • Company Market Share Analysis, 2019
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.